WATCH NOW: Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials
With content flying at us from every direction, it’s easy to miss what matters most. That’s why JDD Corner is your go-to hub for curated, bite-sized info straight from our editorial team—so you can stay sharp without the scroll fatigue.
This month’s standout? A Video Abstract from April 2025’s issue that dives into racial and ethnic representation in atopic dermatitis (AD) clinical trials.
AD affects over 31 million people in the U.S., disproportionately impacting communities of color. Yet a new study in JDD reveals that while representation of Black and Asian participants in clinical trials is improving, Hispanic patients remain significantly underrepresented—despite high disease burden.
Diverse trials lead to better, more equitable care. Watch this video abstract to learn why that matters—and how dermatology research must evolve to serve everyone.
J Drugs Dermatol. 2025;24(4):360-364. doi:10.36849/JDD.8705
